Kagawa, Japan

Suzuko Satou

This inventor holds 1 USPTO granted patent. Top assignee: Shikoku Chemicals Corporation. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suzuko Satou. Retrieved from https://idiyas.com/inventor/suzuko-satou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Suzuko Satou

Introduction

Suzuko Satou is a prominent inventor based in Kagawa, Japan. She has made significant contributions to the field of chemistry, particularly in the synthesis of pharmaceutical intermediates. Her work is characterized by a commitment to innovation and practical applications in medicine.

Latest Patents

Suzuko Satou holds a patent for a process titled "Process for synthesizing 4-halo-5-(hydroxymethyl) imidazole compounds." This process is designed for the industrial-scale preparation of 4-halo-5-(hydroxymethyl) imidazole compounds, which are valuable as intermediates in the development of medicines. The synthesis involves reacting a 4,5-bis(hydroxymethyl) imidazole compound with halogenating agents such as N-chlorosuccinimide or N-bromosuccinimide.

Career Highlights

Satou is currently employed at Shikoku Chemicals Corporation, where she continues to advance her research and development efforts. Her innovative approach has led to the successful synthesis of compounds that are crucial for pharmaceutical applications.

Collaborations

Throughout her career, Suzuko has collaborated with notable colleagues, including Takayuki Murai and Tokuichi Saeki. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Suzuko Satou's contributions to the field of chemistry and her innovative patent demonstrate her dedication to advancing medical science. Her work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…